Prevalence and predictors of persistent low-level HIV viraemia: a retrospective cohort study among people receiving dolutegravir-based antiretroviral therapy in Southern Nigeria.
Ogheneuzuazo OnwahEsther NwanjaUduak AkpanOtoyo ToyoChiagozie NwangenehBabatunde OyawolaAugustine IdemudiaKolawole OlatunbosunOnyeka IgboelinaDolapo OgundehinEzekiel JamesOkezie OnyedinachiAdeoye AdegboyeAndy EyoPublished in: Therapeutic advances in infectious disease (2024)
PLLV was uncommon among individuals receiving dolutegravir-based ART and was associated with longer ART duration, prior viral suppression, and non-receipt of tuberculosis preventive therapy. This strengthens recommendations for continuous adherence support and comprehensive health services with ART, to prevent treatment failure.
Keyphrases
- antiretroviral therapy
- hiv infected
- hiv aids
- hiv infected patients
- hiv positive
- human immunodeficiency virus
- risk factors
- mycobacterium tuberculosis
- clinical practice
- stem cells
- type diabetes
- insulin resistance
- metabolic syndrome
- skeletal muscle
- combination therapy
- pulmonary tuberculosis
- weight loss
- replacement therapy
- men who have sex with men
- hiv testing
- bone marrow